Impact: Supporting Patients Through Grants
Although great progress has been made in the treatment and care of breast cancer patients, there is still more work to be done. Our Global Medical Grant programs support independent research, quality improvement, and education initiatives that fill evidence gaps, improve quality of care, and provide independent medical and patient education initiatives around the world. Pfizer has awarded nearly $200M in global medical grants for breast cancer to date.
As part of our program and in partnership with Conquer Cancer®, the ASCO Foundation, $900,000 has been awarded to recipients across the United States to support studies focused on identifying disparities in delivery of care and treatment outcomes for patients of color with metastatic breast cancer (mBC).
These grants are part of the Pfizer Global Medical Grants program Equitable Care of Metastatic Breast Cancer (mBC) Patients: A Phased Approach to Understanding and Addressing Healthcare Disparities for People of Color which aims to promote and advance scientific knowledge concerning equitable care of patients with mBC by employing data-driven frameworks to define and address inequities in the delivery of patient care and outcomes.
About Conquer Cancer, the ASCO FoundationConquer Cancer, the ASCO Foundation funds research for every cancer, every patient, everywhere. In 1964, 7 oncologists created the American Society of Clinical Oncology (ASCO), now a global network of nearly 45,000 cancer professionals. As ASCO’s foundation, they support groundbreaking research and education so both doctors and patients have the resources they need. For more information, visit CONQUER.ORG.
Grant recipients are currently conducting a deep, data-based analysis of inequities within their own systems across a myriad of variables, including but not limited to socioeconomic determinants of access to care and point-of-care entry, age, financial barriers to care, and inequities in rural vs urban healthcare delivery.